
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. Diabetes: Medtronic gets in on $17m Series B for Glooko
Medtronic got in on a $16.5 million Series B round for Glooko and its diabetes management platform, joining fellow new investor Canaan Partners and existing backers The Social + Capital Partnership and Samsung.
Palo Alto, Calif.-based Glooko’s platform is designed to link more than 30 blood glucose testing systems with Apple’s iPhone or Google’s Android smartphones. Data from the glucometers is then sent to Glooko’s cloud-based Population Tracker, where healthcare providers receive a “simple-to-interpret, risk-stratified” view, the Palo Alto, Calif.-based company said. Read more
2. Becton Dickinson closes $12B CareFusion buyout
Becton Dickinson closed its $12.2 billion merger with CareFusion, as expected after European anti-trust regulators last week approved the deal.
Franklin Lakes, N.J.-based Becton agreed last October to pay a total of $58.00 a share – $49.00 in cash and 0.0777 of a BDX share – for each CFN share, representing a premium of 26% to the closing price on Oct. 3. Read more
1. Zimmer chooses new bellwethers in NexGen knee implant MDL
Zimmer chose another set of lawsuits to serve as bellwether cases in the multi-district litigation over its NexGen knee implants.
More than 5,900 NexGen product liability lawsuits have been consolidated under Judge Rebecca Pallmeyer of the U.S. District Court for Northern Illinois. Read more